Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004526
Filing Date
2025-02-18
Accepted
2025-02-18 20:15:11
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02182025_080208.html 4  
1 form4-02182025_080208.xml 4 4077
  Complete submission text file 0001415889-25-004526.txt   5593
Mailing Address C/O BEJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Business Address
Powell Fred M (Reporting) CIK: 0001331339 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40241 | Film No.: 25636877

Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)